Cacao Flavanol Exercise Performance Meta-analysis: What the Evidence Says
Cacao Flavanol Exercise Performance Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this firs
Quick Answer
Cacao Flavanol Exercise Performance Meta analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence aware guidance rather than medical advice.
Key Takeaways
- 01This page is generated only from sources stored in the Migaku evidence knowledge base.
- 02Current evidence mix: 1 systematic review, 1 narrative review.
- 03Claims should be interpreted with the source type, study design, population, and publication date in mind.
- 04This article is educational and does not replace care from a qualified clinician.
Cacao Flavanol Exercise Performance Meta-analysis: What the Evidence Says
Quick Answer
Cacao Flavanol Exercise Performance Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.
Key Takeaways
- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 systematic review, 1 narrative review.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.
Evidence Map
| Source | Evidence type | Level | Date | Identifier |
|---|---|---|---|---|
| Response of VO 2max to dark chocolate consumption in healthy subjects: A systematic review and meta‐analysis of randomized controlled trials | systematic review | 1 | 2025-02-25 | 10.14814/phy2.70256 |
| Beyond Taste: The Impact of Chocolate on Cardiovascular and Steatotic Liver Disease Risk Factors | narrative review | 3 | 2026-02-14 | 10.3390/nu18040636 |
What The Sources Report
- Studies have indicated that higher levels of aerobic capacity are associated with improved athletic performance and a reduced risk of cardiovascular diseases, as well as lower mortality rates in non-athletes (McKendry et al., ). [Mehdipour Aref (2025); evidence level 1]
- Overall, enhancing aerobic capacity can contribute to improved quality of life and better public health (Blair et al., ; Kodama et al., ; Lee et al., ). [Mehdipour Aref (2025); evidence level 1]
- MetS is a multifactorial condition, with its primary indicators including obesity, hypertension, dyslipidemia, insulin resistance, and hyperglycemia; i.e., a patient who possesses at least 3 of the following parameters is designated with MetS: glucose intolerance, increased levels of triglycerides, augmented waist circumference, low levels of high-density lipoprotein cholesterol (HDL-c), and hypertension. [Tomaru Júlia Mayumi (2026); evidence level 3]
- It is possible to develop a close relationship with MetS, metabolic dysfunction-associated steatotic liver disease (MASLD), and CVD. [Tomaru Júlia Mayumi (2026); evidence level 3]
How To Read This Evidence
Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.
Practical Interpretation
There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For cacao flavanol exercise performance meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.
Limits Of This First Pass
This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.
References
- Mehdipour Aref (2025). Response of VO 2max to dark chocolate consumption in healthy subjects: A systematic review and meta‐analysis of randomized controlled trials. DOI: 10.14814/phy2.70256. PMCID: PMC11859664. PMID: 40000922. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC11859664/
- Tomaru Júlia Mayumi (2026). Beyond Taste: The Impact of Chocolate on Cardiovascular and Steatotic Liver Disease Risk Factors. DOI: 10.3390/nu18040636. PMCID: PMC12943539. PMID: 41754152. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12943539/
Safety Note
Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.
FAQ
Frequently Asked Questions
Medically reviewed
Last reviewed August 7, 2026 by Migaku Evidence Review
